DFG TI239/16-1 (PI Timmann)) Ethics declarations Conflicts of Interest LN Miterko, J Beckinghausen, RV Sillitoe: None LV Bradnam, AB McCambridge: None J Cooperrider, KB Baker, A Machado: None M Hallett: Member of the scientific advisory board of Brainsway T Popa: None DH Heck: None T Wichmann, MR DeLong: None SV Gornati, FE Hoebeek: None AZ Kouzani: None S-H Kuo, T Xie, ED Louis: None M Manto, N Oulad Ben Taib: None MA Nitsche: Member of the scientific advisory board of Neuroelectrics M Tanaka: None D Timmann: None MY Cheng, EH Wang, GK Steinberg: None Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
SSTR-mediated anti-secretory effects are induced via two main pathways: (1) inhibition of adenylyl cyclase (AC) resulting in reduced levels of cyclic AMP (cAMP) and (2) activation of K + -channels and inhibition of voltage-dependent Ca 2+ -channels resulting in reduced intracellular Ca 2+ levels (Fig
These findings were strongest in African Americans
However, peptides and medications that target appetite regulation and feelings of fullness are generally associated with the most significant weight-loss outcomes
Clinical trials extending 68 weeks show acceptable safety profiles with no unexpected serious adverse events
